John Johnston | Clinical Assessor

John Johnston, Clinical Assessor, MHRA

John was a consultant in metabolic disorders in the UK’s National Health Service and transferred to the MHRA(UK) in 2007 where he now assesses advanced therapy medicinal products in the Biologicals Unit.

John has published on several aspects of metabolic disorders; more recently he has published on the challenges of personalised medicine being faced by current legislation.


Conference Day 1: Thursday 16th May 2019 @ 12:10

Technology and Strategy Roundtables

25 senior level tables hosted by thought leaders on key challenges and opportunities in next-generation therapeutic development. Participants are invited to join the group discussions on a topic of importance to them.

· At each roundtable, the moderator will talk for 5 minutes to introduce the topic highlighting particular challenges specific to that area· The table will then move on to discussion for 25 minutes.· There will then be one rotation, giving participants the opportunity to have join two round tables in total

(2 x 30-minute rotations and max 15 PAX)

Table 9. How companies can interact with the regulator and various pitfalls to be aware of (aimed at start-up companies and those from outside the EU (not used to EU or UK ways)

last published: 14/May/19 13:35 GMT

back to speakers

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.